DalsnaFinance

Bausch & Lomb $BLCO

Health Care

Canada
Create a scorecard
$17.43
+0.25 (+1.46%)
As of Oct 22, 2026, 6:58 PM EDT
Price history
Loading chart…

Bausch & Lomb (BLCO) is trading up at $17.43 (+1.46%), as of the latest quote. It operates in the Health Care sector.

IPO: May 6, 2022 · $18.00 offering · NYSE · View IPO details →

Bausch & Lomb revenue & net income history (FY2020–FY2025)

RevenueNet incomeNet margin (right axis, %)
$5.10B$2.37B−$360.0MFY2020 revenue: $3.41BFY2020 net income: −$18.0M · Net margin −0.5%'20FY2021 revenue: $3.77BFY2021 net income: $182.0M · Net margin 4.8%'21FY2022 revenue: $3.77BFY2022 net income: $6.00M · Net margin 0.2%'22FY2023 revenue: $4.15BFY2023 net income: −$260.0M · Net margin −6.3%'23FY2024 revenue: $4.79BFY2024 net income: −$317.0M · Net margin −6.6%'24FY2025 revenue: $5.10BFY2025 net income: −$360.0M · Net margin −7.1%'250%5%10%15%20%FY2020 net margin: −0.5%FY2021 net margin: 4.8%FY2022 net margin: 0.2%FY2023 net margin: −6.3% (off the scale, which stops at −1.4%)FY2024 net margin: −6.6% (off the scale, which stops at −1.4%)FY2025 net margin: −7.1% (off the scale, which stops at −1.4%)
Bausch & Lomb annual financial statements
FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$3.41B$3.77B$3.77B$4.15B$4.79B$5.10B
Growth (year over year)—+10.3%+0.1%+10.0%+15.6%+6.5%
Operating income$260.0M$329.0M$207.0M$130.0M$162.0M$113.0M
Operating margin7.6%8.7%5.5%3.1%3.4%2.2%
Net income−$18.0M$182.0M$6.00M−$260.0M−$317.0M−$360.0M
Net margin−0.5%4.8%0.2%−6.3%−6.6%−7.1%
EPS (diluted)−$0.05$0.52$0.02−$0.74−$0.90−$1.02
Balance sheet
Cash and equivalents$238.0M$174.0M$354.0M$331.0M$305.0M$383.0M
Total assets—$10.8B$11.1B$13.4B$13.5B$14.0B
Total liabilities—$1.42B$4.04B$6.52B$6.92B$7.50B
Long-term debt—$0$2.41B$4.53B$4.74B$5.02B
Shareholders' equity$9.99B$9.33B$7.03B$6.85B$6.47B$6.45B
Cash flow
Operating cash flow$522.0M$873.0M$345.0M−$17.0M$232.0M$283.0M
Capital expenditure$253.0M$193.0M$175.0M$181.0M$291.0M$349.0M
Free cash flow$269.0M$680.0M$170.0M−$198.0M−$59.0M−$66.0M

From Bausch & Lomb's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Bausch & Lomb

Bausch & Lomb is a Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company was founded in Rochester, New York, in 1853 by optician John Bausch and cabinet maker turned financial backer Henry Lomb. Until its sale in 2013, Bausch + Lomb was one of the oldest continually operating companies in the United States.

Source: Wikipedia — Bausch & Lomb

Headquarters
Vaughan, Canada From SEC filings, Oct 2026

Recent News (1)

More Health Care stocks

Browse all companies →